Gunjan Verma - India

“Once implemented, the new rules will affect all medical devices, including those already registered under an Import License.”

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

UDI Requirements in India Temporarily Delayed

Published on: January 17th, 2022

UDI Requirements in India Delayed Indefinitely

On December 31, 2021, the Indian Ministry of Health and Family Welfare and Department of Health and Family Welfare issued the FINAL NOTIFICATION for the amendment of Rule 46 of Medical Device Rule 2017 delaying the implementation of UDI requirements in India. Feedback was previously invited on an issued draft notification till December 28, 2021.  According to Rule 46 of the Medical Device Rules, new UDI regulations in India for the medical devices were to be displayed on the medical devices approved for manufacture, for sale, or distribution or import, by January 1, 2022. However, this has now been delayed until further guidance is provided.

With the current notification amending Rule 46, a new timeline will be specified by the Ministry of Health and Family Welfare in the future. MOHFW is also expected to provide guidance on how the Unique Device Identification number has to be displayed on the medical devices that are manufactured or imported and what information it needs to contain. While the requirements have been delayed for an unspecified amount of time, it is expected that additional guidance will be released in 2022.

As stated in the Notification:

Rule 46 of Medical Devices Rules, shall be substituted with:

“46. Unique device identification of medical device.— With effect from such date as the Central Government may, by order specify, every medical device approved for manufacture for sale or distribution or import, shall bear a unique device identification in the manner as may be specified in such order.”

While many international manufacturers have already implemented UDI, it will be important for manufacturers not already utilizing it to stay informed of new UDI regulatory updates in India.

New UDI Requirements to be Based on IMDRF Guidance

UDI requirements in India are expected to be based on IMDRF UDI Guidance which requires the label to include both a human readable form and an AIDC carrier. The Unique Device Identifier (UDI) is composed of two parts: Device Identifier (UDI-DI) and Production Identifier (UDI-PI). The IMDRF’s guidance is meant to help various markets harmonize their standards to support identification and distribution of products used by patients.

Come Grow With Us

Asia Actual is available to help navigate the complex and changing medical device registration requirements and regulatory pathway for medical device and IVD distribution in India.

Contact Asia Actual for a free consultation to discuss the potential of your medical device or IVD in the Indian medical market.

Blog Posts

China’s NMPA Updates Medical Device Classification Catalogue

China’s National Medical Products Administration (NMPA) maintains a list of all medical device categories called the Medical Device Classification Catalogue. NMPA published a notice on August 17, 2023, that they had released amendments to the Medical Device Classification Catalogue. It’s important for manufacturers to understand these changes as they can significantly impact the cost and time to register medical devices.

Thai FDA Drafting New Guidance for SaMD and AI Device Registration

Thai FDA is drafting new guidelines for AI Regulation. The novel characteristics of artificial intelligence (AI) software cause issues with the medical device registration process in most countries. The Thai Food and Drug Administration (Thai FDA) is working to address this important issue, most recently by hosting a meeting with interested parties on July, 2023, which Asia Actual Thailand employees were invited to attend.

China NMPA Adds 47 Products to Clinical Trial Exemption List

China’s National Medical Products Administration (NMPA) updated its clinical trial exemption list, adding 47 products. The NMPA updates this list every two to three years, with the last amendment in 2021. This brings the total number of clinical trial exempted product categories in China to 1,025.